Skip to main content
. 2017 Aug 30;7:9974. doi: 10.1038/s41598-017-09707-y

Figure 2.

Figure 2

PTEN silencing in control PASMCs induces increased pAKT levels. Commercially available PASMCs were transfected with siRNA for PTEN or control non-targeting siRNA (scrambled siRNA), with 10% FBS used for the control group. Representative immunoblot (a) and densitometric quantification (b) of protein expression after siRNA transfection. The bars represent the mean ± SEM for n = 3 samples. **P < 0.01, ***P < 0.001 compared with the 10% FBS control group.